cardiology careers collections past issues search home
     

J Am Coll Cardiol, 1999; 33:1400-1407
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iwasaki, A.
Right arrow Articles by Sasayama, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iwasaki, A.
Right arrow Articles by Sasayama, S.

Pimobendan inhibits the production of proinflammatory cytokines and gene expression of inducible nitric oxide synthase in a murine model of viral myocarditis

Atsushi Iwasaki, MDa, Akira Matsumori, MD, PhD, FACCa, Takehiko Yamada, MD, PhDa, Tetsuo Shioi, MD, PhDa, Weizhong Wang, MD, PhDa, Koh Ono, MD, PhDa, Ryosuke Nishio, MDa, Masaharu Okada, MDa and Shigetake Sasayama, MD, PhD, FACCa

a Department of Cardiovascular Medicine, Kyoto University, Kyoto, Japan



View larger version (15K):

[in a new window]
 
Figure 1 Effect of pimobendan on survival rate after EMC virus inoculation. Beyond seven days, the survival rate was improved in a dose-dependent manner. Treatment with pimobendan, 1 mg/kg/day, significantly reduced mortality on day 14. * = p < 0.02 versus control. Each group consists of thirty mice.

 


View larger version (154K):

[in a new window]
 
Figure 2 Typical histopathologic changes found seven days after EMC virus inoculation. A and B: Heart from a control mouse. C and D: Heart from a mouse treated with pimobendan 1 mg/kg. Extensive myocardial necrosis and cellular infiltration are found in the control preparation. In the mouse treated with pimobendan, less myocardial cellular infiltration exists despite an equivalent amount of myocardial necrosis. Hematoxylin and eosin stain—original magnification: A and C, x 40, reduced by 65%; B and D, x 200, reduced by 65%.

 


View larger version (19K):

[in a new window]
 
Figure 3 Effect of pimobendan on intracardiac production of TNF-{alpha}, IL-1ß, and IL-6 measured on day seven after EMC virus inoculation. The intracardiac TNF-{alpha} and IL-1ß level in animals treated with pimobendan 1 mg/kg (n = 7) were significantly lower than those in the control group (n = 5). * = p < 0.001 versus control. ** = p < 0.01 versus control. The intracardiac IL-6 level in the animals treated with pimobendan 1 mg/kg was also less than in the control group, but the difference did not reach statistical significance.

 


View larger version (27K):

[in a new window]
 
Figure 4 Effect of pimobendan on intracardiac NO production. The concentrations of nitrite/nitrate, stable endproducts of NO, in the pimobendan 1 mg/kg group (n = 5) were 43% lower than in the control group (n = 5). * = p < 0.01 versus control.

 


View larger version (41K):

[in a new window]
 
Figure 5 Quantification of iNOS mRNA in the hearts using RT-PCR. A: Total RNA was extracted from the hearts in the pimobendan 1 mg/kg group and the control group. Each PCR product was separated by electrophoresis on a 5% polyacrylamide gel. The gels were dried and autoradiographed. nh-DNA = nonhomologous DNA. B: The log of the ratio of iNOS or G3PDH target radioactivity to the nh-DNA fragment radioactivity was plotted against the log of the number of the nh-DNA fragment molecules added to each PCR reaction. The number of iNOS or G3PDH cDNA molecules was obtained from the point where log (iNOS or G3PDH/the nh-DNA fragment) was equal to zero. C: The number of iNOS or G3PDH cDNA was expressed as attomoles/µg of total RNA. The iNOS gene expression in the pimobendan 1 mg/kg group was 74% lower than that of the control group. * = p < 0.01 versus control.

 




 
  cardiology careers collections past issues search home